Sepsis and septic complications in the surgical patient: Who is at risk?

Shock

Volumn 6, Issue 6 SUPPL., 1996, Pages

  Cheadle, William G ^a,b   Mercer Jones, Mark ^a   Heinzelmann, Michael ^a   Polk Jr , Hiram C ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA DR ANTIGEN;

CELLULAR IMMUNITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INJURY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; REVIEW; RISK FACTOR; SEPSIS; TRANSPLANTATION;

CYTOKINES; HLA-DR ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEPSIS; TRANSPLANTATION; WOUNDS AND INJURIES;

EID: 0029682727     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199610001-00003     Document Type: Article

References (42)

1. Wangensteen OH, Wangensteen SD: The Rise of Surgery: From Empiric Craft to Scientific Discipline. Minneapolis: University of Minnesota Press, 1978, pp 16-52.
2. Miles AA, Miles EM, Burke J: The value and duration of defense reactions of the skin to the primary lodgement of bacteria. Br J Exp Pathol 38:79-96, 1957.
3. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). JAMA 273:117-123, 1995.
4. Bone RC: Sepsis, the sepsis syndrome, multiorgan failure: A plea for comparable definitions. Ann Intern Med 114:332-333, 1991.
5. Fulton RL, Jones CE: The causes of posttraumatic pulmonary insufficiency in man. Surg Gynecol Obstet 140:179-186, 1975.
6. McCabe WR, Jackson GG: Gram-negative bacteremia: Clinical, laboratory, and therapeutic observations. Arch Intern Med 110:856-864, 1962.
7. Kreger BE, Craven DE, Carling PC, McCabe WR: Gram-negative bacteremia: Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Surg 68:332-343, 1980.
8. Kreger BE, Craven DE, McCabe WR: Gram-negative bacteremia: Reevaluation of clinical features and treatment in 612 patients. Am J Surg 68:344-355, 1980.
9. Dellinger EP, Wertz MJ, Meakins JL, Solomkin JS, Allo MD, Howard RJ, Simmons RL: Surgical infection stratification system for intra-abdominal infection. Arch Surg 120:21-29, 1985.
10. Knaus WA, Harrell FE, Fisher CJ, Wagner DP, Opal SM, Sadoff JC, Draper EA, Walawander CA, Conbody K, Grasela TH: The clinical evaluation of new drugs for sepsis: A prospective study design based on survival analysis. JAMA 210:1233-1241, 1993.
11. Baker CC, Openheimer L, Stephens B, Lewis FR, Trunkey DD: The epidemiology of deaths. Am J Surg 140:144-150, 1980.
12. Stephan RN, Kupper TS, Qeha AS, Baue AE, Chaudry IH: Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 122:62-68, 1987.
13. Livingston DH, Malangoni MA: Prolonged susceptibility to infection exists after hemorrhagic shock despite resuscitation and antibiotics. Surg Forum 38:64, 1987.
14. Nichols RL, Smith JW, Klein DB, Trunkey DD, Cooper RH, Adinolfi MF, Mills J: Risk of infection after penetrating abdominal trauma. N Engl J Med 311:1065-1070, 1984.
15. Polk HC Jr, Heinzelmann M, Mercer-Jones M, Malangoni MA, Cheadle WG: Pneumonia in the surgical patient. Curr Probt Surg (in press).
16. Faist E, Kupper T, Baker CC, Chaudry IH, Dwyer J, Baue AE: Depression of cellular immunity after major injury: Its association with post traumatic complications and its reversal with immunomodulation. Arch Surg 121: 1000-1005, 1986.
17. Christou NV, Meakins JL: Neutrophil function in anergic surgical patients: Neutrophil adherence and chemotaxis. Ann Surg 190:557-564, 1979.
18. Hershman MJ, Cheadle WG, Appel SH, George CD, Davidson PF, Cost KM, Polk HC Jr: Comparison of antibody response with delayed hypersensitivity in severely injured patients. Arch Surg 124:339-341, 1989.
19. Cheadle WG, Pemberton M, Robinson D, Livingston DH, Rodriguez JL, Polk HC Jr: Lymphocyte subset responses to trauma and sepsis. J Trauma 35:844-849, 1993.
20. Suzuki R, Pollard RB: Alterations of interferon production in a mouse model of thermal injury. J Immunol 129:1806-1810, 1982.
21. Polk HC Jr, Cheadle WG, Livingston DH, Rodriguez JL, Starko KM, Izu AE, Jaffe HS, Sonnenfeld G: A randomized prospective clinical trial to determine the efficacy of interferon gamma in severely injured patients. Am J Surg 163:191-196, 1992.
22. Ayala, A, Perrin MM, Chaudry IH: Defective macrophage antigen presentation following hemorrhage is associated with the loss of MHC class II (Ia) antigens. Immunology 70:33-39, 1990.
23. Ertel W, Morrison MH, Ayala A, Dean RE, Chaudry IH: Interferon-gamma attenuates hemorrhage-induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery 111: 177-187, 1992.
24. Faist E, Mewes A, Strasser T, Walz A, Alkan S, Baker C, Ertel W, Heberer G: Alteration of monocyte function following major injury. Arch Surg 123:287-292, 1988.
25. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr: Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 77:204-207, 1990.
26. Hershman MJ, Cheadle WG, Kuftinec D, Polk HC Jr, George CD: An outcome predictive score for sepsis and death following trauma. Injury 19:263-266, 1988.
27. Cheadle WG, Hershman MJ, Wellhausen SR, Polk HC Jr: HLA-DR antigen expression on peripheral blood monocytes correlates with surgical infection. Am J Surg 161:639-645, 1991.
28. Oswald IP, Gazzinelli RT, Sher A, James SL: IL-10 synergizes with IL-4 and transforming growth factor to inhibit macrophage cytotoxic activity. J Immunol 148:3578-3582, 1992.
29. Chaudry IH, Ayala A: Mechanism of increased susceptibility to infection following hemorrhage. Am J Surg 165(Suppl 2A):59-66, 1993.
30. Vercelli D, Jabara HH, Lauener RP, Geha RS: IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 144:570-573, 1990.
31. Di Piro J, Hamilton RG, Howdieshell TR, Adkinson NF, Mansberger AR: Total IgE in plasma is elevated after traumatic injury and is associated with sepsis syndrome. Ann Surg 215:460-466, 1992.
32. deWaal Malefyte R, Haanen J, Spits H, Roncarolo MG, Te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 and viral IL-10 strongly reduce antigen specific T-cell proliferation by diminishing the antigen presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 174:915-924, 1991.
33. Rodriguez JL, Miller CG, DeForge LE, Kelty L, Shanley CJ, Bartlett RH, Remick DG: Local production of interleukin-8 is associated with nosocomial pneumonia. J Trauma 33:74-82, 1992.
34. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989.
35. Hershman MJ, Cheadle WG, George CD, Cost KM, Appel SH, Davidson PF, Polk HC Jr: The response of immunoglobulins to infection after thermal and nonthermal injury. Am Surg 54:408-411, 1988.
36. Polk HC Jr, George CD, Hershman MJ, Wellhausen SR, Cheadle WG: The capacity of serum to support neutrophil phagocytosis is a vital host defense mechanism in severely injured patients. Ann Surg 207:686-692, 1988.
37. Polk HC Jr, George CD, Wellhausen SR, Cost K, Davidson PR, Regan MP, Borzotta AP: A systemic study of host defense processes in badly injured patients. Ann Surg 204:282-299, 1986.
38. Lanser ME, Mao P, Brown G, Coleman B, Siegel JH: Serum-mediated depression of neutrophil chemiluminescence following blunt trauma. Ann Surg 202:111-118, 1985.
39. Dries DJ, Jurkovich GJ, Maier RV, Clemmer TP, Struve SN, Weigelt JA, Stanford GG, Herr DL, Champion HR, Lewis RN, Hoyt D, Hansbrough J, Yellin AE, Berne TV, Trunkey DD, Jaffe HS, Munera C, Fisher P, Starko K: Effect of interferon gamma on infection-related death in patients with severe injuries: A randomized, double-blind, placebo-controlled trial. Arch Surg 129:1031-1041, 1994.
40. Fisher CJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA, The IL-IRA Sepsis Syndrome Study Group: Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 22:12-21, 1994.
41. Ziegler EJ, Fisher CJ, Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NNH, Allen IE, Berger HJ, Knatterud GL, LoBuglio AF, Smith CR, The HA-1A Sepsis Study Group: Treatment of Gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324:429-435, 1991.
42. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, Pennington JE, Wherry JC, The TNF-α MAb Sepsis Study Group: Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. JAMA 273:934-941, 1995.